58814-69-0

4,5-Dimethoxy-2-methylbenzonitrile is an intermediate for the synthesis of Terazosin-md (T105020), an analog of Terazosin (T105000), which is an α1-adrenergic receptor antagonist alleviating organ damage in studies done on rodent models of stroke and sepsis and has potential to be used for treatment for diseases.